Caricamento...
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
BACKGROUND: Oral tacrolimus is a therapeutic agent for moderate to severe steroid-dependent or resistant ulcerative colitis (UC), but remission induction is difficult, and it is necessary to treat the patient while considering the next treatment. AIM: To examine serum albumin (Alb) level as a progno...
Salvato in:
| Pubblicato in: | World J Gastroenterol |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8192282/ https://ncbi.nlm.nih.gov/pubmed/34168412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i22.3109 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|